Family Practice, Hospital, Hypertension and Internal Medicine

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Family Practice

Hospital

Hypertension

Internal Medicine

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

JUNE 11, 2025

Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. “I am very excited and pleased to have Widaplik approved for the treatment of hypertension in the U.S. ” The approval of Widaplik was granted to George Medicines.

Hypertension

Hypertension Diabetes Patients Medical

DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes

Physician's Weekly

JUNE 18, 2025

WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. Pilla, M.D.,

Diabetes

Diabetes Internal Medicine Hypertension Clinic

Primary Care Digest

FDA Approves Polypill Widaplik for Hypertension

DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes

Stay Connected